Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age.
Elissa Malkin*, Ram Yogev, Nazha Abughali, Joseph Sliman, C. Kathy Wang, Fengrong Zuo, Chin Fen Yang, Mark Eickhoff, Mark T. Esser, Roderick S. Tang, Filip Dubovsky
Dive into the research topics of 'Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age.'. Together they form a unique fingerprint.